Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers publish data on VIP-236 as a promising antitumoral agent

Feb. 8, 2022

Novel PSCA CAR_s15 NK cell immunotherapy prolongs survival in pancreatic cancer model

Feb. 8, 2022

Navidea sponsors research at Penn to evaluate Tc99m tilmanocept as prognostic marker in glioblastoma

Feb. 8, 2022

In vitro data show proof of concept for Theralase SARS-CoV-2 vaccine

Feb. 8, 2022

Wuhan LL Science and Technology Development presents new ROCK inhibitors

Feb. 8, 2022

Chiesi Farmaceutici identifies new TGFBR1 inhibitors for IPF

Feb. 8, 2022

Beijing Tide Pharmaceutical synthesizes new ATR kinase inhibitors

Feb. 8, 2022

Researchers divulge SSTR4 agonists for treatment of pain

Feb. 8, 2022

Roche patents new TLR antagonists for autoimmune disease

Feb. 8, 2022

Heterozygous variants in the CD36 gene linked to bleeding phenotypes

Feb. 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...